CURRICULUM VITAE
Katsuhiko
Ito, MD, PhD
PERSONAL
INFORMATION
Date of Birth: August
9, 1959
Place of
Birth: Kawasaki, Japan
Citizenship: Japan
Professional address: Miyamaedaira
GP Clinic
2-15-2, Miyamaedaira, Miyamae, Kawasaki, Kanagawa,
216-0006, Japan
Tel:
+81-44-860-4119 Fax: +81-44-860-4199
E-mail address: k.ito@carekarte.com
EDUCATION/POST GRADUATE
TRAINING
‘ College/University: 1979-1985 MD,
Kyoto Prefectural University of Medicine, Kyoto, Japan
‘ 1993-1995 PhD
in the Secretion of Islet Hormones, Physiology,
’ Keio University School of Medicine, Tokyo, Japan
‘ Residency: 1985-1987 Resident
in Internal Medicine,
’ Keio
University School of Medicine, Tokyo, Japan
’ 1987-1989 Resident
in Internal Medicine, Nihon Kokan Hospital, Kawasaki, Japan
‘ Fellowship: 1989-1993 Fellow
in Endocrinology and Metabolism, Internal Medicine,
’ Keio
University School of Medicine, Tokyo, Japan
MEDICAL
LICENSURE
Full Medical License (Japan) #293697
BOARD CERTIFICATION
Dec 1990 Fellow
of the Japanese Society of Internal Medicine. #1091
Dec 1996 Board
Certified Diabetologist of Japan Diabetes Society. #2235
Feb 2000 Board
of the Long-term Care Insurance Management. #99B5023
’ The
license of Care Manager, Kanagawa, Japan. #14992028
PRESENT
POSITION OR ACADEMIC RANK
May 1998-present President
& CEO Miyamaedaira GP Clinic,
Kawasaki, Japan
Jul 2000-present President
& CEO CareKarte Inc., Kawasaki, Japan
’ The
Long-term Care Insurance Management Agency,
’ Japan
Medical Association Standard Receipt Software Agency,
’ Temporary
Computer-Software Operator Agency.
PREVIOUS PROFESSIONAL
POSITIONS AND APPOINTMENTS
May 1993-May 1995 Instructor:
Division of Endocrinology and Metabolism,
’ Internal
Medicine, Keio University School of Medicine, Tokyo, Japan
May 1995-May 1997 Division
Chief: Division of Diabetes Mellitus,
’ Internal
Medicine, Inagi Municipal Hospital, Tokyo, Japan
May 1997-May 1998 Director
of Internal Medicine, Aiseikai Arima
Hospital, Kawasaki, Japan
TEACHING ACTIVITIES-HOSPITAL OR OFFICE-BASED
May 1993-May 1995 Instructor:
Division of Endocrinology and Metabolism,
’ Internal
Medicine, Keio University School of Medicine, Tokyo, Japan
May 1995-May 1997 Division
Chief: Division of Diabetes Mellitus,
’ Internal
Medicine, Inagi Municipal Hospital, Tokyo, Japan
May 1997-May 1998 Director
of Internal Medicine, Aiseikai Arima Hospital, Kawasaki, Japan
HOSPITAL/UNIVERSITY
COMMITTEE APPOINTMENTS
May 1993-May 1995 Director
of Patient-Education-Planning Office of Diabetes Mellitus,
’ Inagi Municipal Hospital, Tokyo, Japan
May 1997-May 1998 Senior
Staff of Ethical Committee, Chairman of Nosocomial Infection Committee
’ Aiseikai Arima Hospital, Kawasaki, Japan
PROFESSIONAL AND SOCIETY MEMBERSHIPS
Fellowship
’ 1990 The
Japanese Society of Internal Medicine
’ 1996 Japan
Diabetes Society
Membership
’ 1987 The
Japanese Society of Internal Medicine
’ 1989 Japan
Diabetes Society
’ 1989-98 American
Diabetes Association
’ 1994 American
College of Physicians-American Society of Internal Medicine
’ 1998 Japan
Medical Association
’ 1998 The
Japan Society for Oriental Medicine
’ 1998 Japanese
Society of Sonographers
’ 2006 Japan
Society for the Study of Obesity
COLLEGE ACTIVITIES
May 4th 2007 ACP
Japan Chapter Annual
Meeting, Osaka
LECTURES/PRESENTATIONS GIVEN AT LOCAL, CHAPTER, NATIONAL, INTERNATIONAL MEETINGS
Local
Nov 2000 38th
Annual Meeting, the Tohoku District of Japan Diabetes Society, Sendai, Japan.
’ “The Method to Diagnose
Diabetes Mellitus using Fasting and 30 min Plasma Glucose
’ of Oral Glucose Tolerance
Test Results”
Jan 2001 38th
Annual Meeting, the Kanto-Koshinetsu District of Japan Diabetes Society, Tokyo, Japan.
’ “The Method to Diagnose
Diabetes Mellitus using Fasting and 60 min Plasma of Oral Glucose
’ Tolerance Test Results”
Mar 2006 Educational
Meeting, Kawasaki Diabetes Society, Kawasaki, Japan.
’ “Metabolic
Syndrome and Diabetes Mellitus”
National
May 2007 50th
Annual Meeting of Japan Diabetes Society, Sendai, Japan.
’ “The Insulin Secretion and
the Insulin Resistance in Japanese People”
International
Jun 1993 53rd Annual
Meeting, Scientific Session of the American Diabetes Association, Las Vegas, USA.
‘ “Exogenous
insulin dose-dependently suppresses glucopenia-induced glucagon secretion
’ from perfused rat
pancreas”
Jun 1994 54th
Annual Meeting, Scientific Session of the American Diabetes Association, New
Orleans, USA.
‘ “Adrenoceptor
antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion
’ from perfused rat
pancreas”
Jun 1994 54th
Annual Meeting, Scientific Session of the American Diabetes Association, New
Orleans, USA .
’ “Acetylcholine
restores insulin and glucagon secretion in response to glucose changes
’ from the perfused
streptozotocin-induced-diabetic‘rat pancreas”
Nov 1994 15th
IDF Congress, International Diabetes Federation Congress, Kobe, Japan.
’ “Acetylcholine
and noradrenalin modulation of insulin and glucagon secretion in response to
glucose
’ concentration
change from the perfused streptozotocin-induced diabetes rat pancreas”
Nov 1994 Symposium:
Glucagon and related peptide, Osaka, Japan.
‘ “Exogenous
insulin dose-dependently suppress glucopenia-induced glucagon secretion
’ from
perfused rat pancreas”
Nov 1994 15th
IDF Congress, International Diabetes Federation Congress, Kobe, Japan.
‘ “Acetylcholine
modulation of insulin and glucagon secretion from the perfused rat pancreas”
Sep 1996 32nd
Annual Meeting European Associations the Study of Diabetes; Vinna, Austria.
‘ “Role
of muscarinic receptor on insulin and glucagon secretion in perfused rat
pancreas”
COMMUNITY ACTIVITIES
May 1998-present Volunteer
Doctor, Kawasaki City Emergency Center, Kawasaki, Japan
May
1998-present Member,
Miyamae Branch of Japan Medical Association, Kawasaki, Japan
May
1998-present Teaching
Staff of Japanese
Certification Board for Diabetes Educator,
’ Kawasaki Diabetes
Society, Kawasaki, Japan
Feb
2000-present Care
Manager: The Long-term Care Insurance System Management for Patients,
’ Kanagawa,
Japan
Oct 2004-present Member
of the Scientific Committee: “The Insulin Secretion and the Insulin
’ Resistance
in Japanese People”, Japan Diabetes Society, Tokyo, Japan
Apr 2005-present Chairman
of the Long-term Care Requirement Certification,
’ The Long-term Care
Insurance System in Miyamae, Kawasaki, Japan
BIBLIOGRAPHY
Publication-Journals
1.
Koyama
K, Maruyama H, Ito K, Kido K, Saruta T:
Arachidonic acid metabolites and alpha2-adrenoceptor-mediated glucagon
secretion in rats.
Diabetes Research and Clinical Practice 16: 229-232, 1992
2.
Hirose
H, Ito K, Kido K, Koyama K, Maruyama H, Saruta T:
Effects of AY-4166 on pancreatic A- and B-cells: comparative study with
glibenclamide in isolated perfused rat pancreas
in pathogenesis and treatment of NIDDM and its related problems.
ed by Sakamoto N, Albeertic KGMH, Hotta K. Excepta Medica, Amsterdam.
Proceedings of the fourth international symposium on treatment of diabetes
mellitus. Nagoya, 1993: 335-340, 1994
3.
Hirose
H, Maruyama H, Ito K, Seto Y, Kido K, Koyama K, Dan K, Saruta T, Kato K:
Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and
glucagon secretion
in perfused rat pancreas. Pharmacology 48: 205-210, 1994
4.
Hirose
H, Maruyama H, Kido K, Ito K, Koyama K, Tashiro Y, Saruta T:
Alpha- and beta-cell function in obese Zucker (fa/fa) rats : a study with the
isolated perfused pancreas.
Clin Science 86: 311-316, 1994
5.
Hirose
H, Maruyama H, Ito K, Kido K, Koyama K, Saruta T:
Effects of diazoxide on a alpha- and beta-cell function in isolated perfused
rat pancreas.
Diabetes
Res Clin Pract 25: 77-82, 1994
6.
Ito
K,
Maruyama H, Hirose H, Kido K, Koyama K, Kataoka K, Saruta T:
Exogenous
insulin dose-dependently suppresses glucopenia-induced glucagon secretion from
perfused rat pancreas.
Metabolism 44: 358-362, 1995
7.
Ito
K,
Hirose H, Kido K, Koyama K, Maruyama H, Saruta T:
Adrenoceptor
antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion
from perfused rat pancreas.
Diabetes
Res Clin Pract 30: 173-180, 1995
8.
Ito
K,
Hirose H, Maruyama H, Fukamachi S, Tashiro Y, Saruta T:
Neurotransmitters
partially restore glucose sensitivity of insulin and glucagon secretion from
perfused streptozotocin-induced
diabetic rat
pancreas. Diabetologia 38: 1276-1284, 1995
9.
Hirose
H, Maruyama H, Kido K, Ito K, Koyama K, Tashiro Y, Saruta T:
Defective insulin and glucagon secretion in isolated perfused rat pancreata of
diabetic WBN/Kob rats.
Pancreas 10: 71-77, 1995
10. Hirose H, Maruyama H,
Seto Y, Ito K, Fujita T, Dan K, Kanda N, Saruta T, Kato R:
Effects of
D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and
beta-cells:
Comparative
study with glibenclamide. Pharmacology 50: 175-181, 1995
11. Ito K, Wada T, Makimura H,
Matsuoka A:
Vector
autoregressive modeling analysis of frequently sampled oral glucose tolerance
test results.
1. A new
method for quantifying insulin resistance and secretion. Keio J Med
47: 28-36, 1998
12. Ito K, Wada T, Makimura H,
Matsuoka A, Maruyama H, Saruta T:
Vector
autoregressive modeling analysis of frequently sampled oral glucose tolerance
test results.
2.
Insulin resistance and secretion after gastrectomy. Keio J Med
47: 78-84, 1998
Abstracts
1.
Ito
K,
Maruyama H, Hirose H, Kido K, Koyama K, Kataoka K, Saruta T:
Exogenous
insulin dose-dependently suppresses glucopenia-induced glucagon secretion from
perfused rat pancreas.
Diabetes
(abstract)
42: Supplement1 111A, 1993
2.
Ito
K,
Hirose H, Kido K, Koyama K, Maruyama H, Saruta T:
Adrenoceptor
antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion
from perfused rat pancreas.
Diabetes
(abstract)
43: Supplement1 173A, 1994
3.
Ito
K,
Maruyama H, Hirose H, Kataoka K, Saruta T:
Acetylcholine
restores insulin and glucagon secretion in response to glucose concentration
changes from the perfused
streptozotocin-induced-diabetic
rat pancreas. Diabetes (abstract) 43: Supplement1 245A, 1994
CONTINUING MEDICAL EDUCATION
CME Taken
1. 15th Educational Meeting (B-Session) of the Japanese Society of Internal Medicine, Yokohama, May 18, 2003
2. 46th Annual Meeting of Japan Diabetes Society, Toyama, May 22-24, 2003
3. 15th Educational Meeting (A-Session) of the Japanese Society of Internal Medicine, Tokyo, June 8, 2003
4. 47th Annual Meeting of Japan Diabetes Society, Tokyo, May 13-15, 2004
5. 16th Educational Meeting (B-Session) of the Japanese Society of Internal Medicine, Yokohama, June 27, 2004
6. 17th Educational Meeting (A-Session) of the Japanese Society of Internal Medicine, Tokyo, May 22, 2005
7. 17th Educational Meeting (B-Session) of the Japanese Society of Internal Medicine, Yokohama, June 12, 2005
8. 103rd Annual Meeting of the Japanese Society of Internal medicine, Yokohama, April 14-15, 2006
9. 49th Annual Meeting of Japan Diabetes Society, Tokyo, May 25-27, 2006
10. 18th Educational Meeting (A-Session) of the Japanese Society of Internal Medicine, Yokohama, May 28, 2006
11. 104th Annual Meeting of the Japanese Society of Internal medicine, Osaka, April 3-5, 2007
12. 50th Annual Meeting of Japan Diabetes Society, Sendai, May 24-26, 2007